UDG Healthcare acquires US based healthcare communications business

18 July, 2017

The Dublin based company has purchased Cambridge BioMarketing for $35m with the possibility of an additional $5m payment over the next 12 months based on financial targets.

The US firm specialises in orphan and rare disease drug launches, a fast-growing area of drug development and commercialisation.
UDG said the acquisition would provide it with a platform for growth, specifically in Cambridge, Massachusetts and Oakland, California, both of which have a strong biotech presence.